Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

TROPICAMIDE 0.5% EYE DROPS

Tropicamide
$0.6102per ML

Strength

5 mg/mL

Manufacturer

Sandoz Inc.

NDC

61314035401

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

7/23/2025

Active Ingredients

TROPICAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA084305

On Market Since

6/9/2000

Pharmacological Classes

Anticholinergic
Cholinergic Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-11.2%

3Y

-11.2%

5Y

-11.2%

All

-11.2%

Generic Alternatives

1 alternative • Same active ingredient

TROPICAMIDE 0.5% EYE DROP
Generic
24208059064•Bausch & Lomb Incorporated
$0.6102

Related Drugs

Same classification

IPRATROPIUM BR 0.02% SOLN
Generic
00487980102•Nephron Pharmaceuticals Corporation
$0.0529
per ML
DICYCLOMINE 20 MG TABLET
Generic
00143122701•Hikma Pharmaceuticals USA Inc.
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00143122710•Hikma Pharmaceuticals USA Inc.
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00527128201•Lannett Company Inc.
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00527128210•Lannett Company Inc.
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00591079501•Actavis Pharma, Inc.
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00591079510•Actavis Pharma, Inc.
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00832605210•Upsher-Smith Laboratories LLC
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00832605211•Upsher-Smith Laboratories LLC
$0.0555
per EA
DICYCLOMINE 20 MG TABLET
Generic
00904698861•Major Pharmaceuticals
$0.0555
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy